KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Idexx Laboratories (IDXX) Receivables - Net (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Receivables - Net data on record, last reported at $552.4 million in Q4 2025.

  • For Q4 2025, Receivables - Net rose 16.64% year-over-year to $552.4 million; the TTM value through Dec 2025 reached $552.4 million, up 16.64%, while the annual FY2025 figure was $552.4 million, 16.64% up from the prior year.
  • Receivables - Net reached $552.4 million in Q4 2025 per IDXX's latest filing, down from $566.9 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $566.9 million in Q3 2025 and bottomed at $368.3 million in Q4 2021.
  • Average Receivables - Net over 5 years is $458.2 million, with a median of $455.1 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: rose 27.27% in 2021, then grew 3.0% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $368.3 million in 2021, then grew by 8.76% to $400.6 million in 2022, then rose by 14.18% to $457.4 million in 2023, then grew by 3.53% to $473.6 million in 2024, then increased by 16.64% to $552.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $552.4 million in Q4 2025, $566.9 million in Q3 2025, and $560.6 million in Q2 2025.